Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Justin L Grodin, MD MPH
UT Southwestern
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Columbia University Medical Center
New York, New York, United States
Andrew J Einstein, MD PhDMathew S Maurer, MDRecruiting - Cleveland Clinic
Cleveland, Ohio, United States
Christopher Nguyen, MDDeborah H Kwon, MDMazen Hanna, MDW. H. Wilson Tang, MDRecruiting - University of Texas Southwestern Medical Center
Dallas, Texas, United States
Julia Kozlitina, PhDJustin L Grodin, MD MPHLori R Roth, MS, PACMarkey McNutt, MD PhDVlad G Zaha, MD PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Nov 2022
- Primary completion
- 30 Jun 2027
- Completion
- 30 Jun 2027
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 500
- Registry id
- NCT05489549
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.